APA-referens

Yuda, J., Odawara, J., Minami, M., Muta, T., Kohno, K., Tanimoto, K., . . . Miyamoto, T. (2020). Tyrosine kinase inhibitors induce alternative spliced BCR‐ABL (Ins35bp) variant via inhibition of RNA polymerase II on genomic BCR‐ABL. Cancer Sci.

Chicago-stil citat

Yuda, Junichiro, et al. "Tyrosine Kinase Inhibitors Induce Alternative Spliced BCR‐ABL (Ins35bp) Variant Via Inhibition of RNA Polymerase II On Genomic BCR‐ABL." Cancer Sci 2020.

MLA-referens

Yuda, Junichiro, et al. "Tyrosine Kinase Inhibitors Induce Alternative Spliced BCR‐ABL (Ins35bp) Variant Via Inhibition of RNA Polymerase II On Genomic BCR‐ABL." Cancer Sci 2020.

Varning: dessa hänvisningar är inte alltid fullständigt riktiga.